Banned medicines seized in Jaipur: 4 miscreants arrested

Jaipur:  The Central Narcotics Bureau (CBN) team has initiated measures against the illicit trafficking of drugs. They have confiscated a significant shipment of prohibited substances, including Tramadol capsules, Alprazolam tablets, and bottles of Codeine Phosphate Syrup, from Jaipur’s Sodala. Additionally, four individuals have been apprehended, and cash amounting to 42 thousand rupees has been recovered from them.

Deputy Narcotics Commissioner Kota Naresh Bundel stated that officials from the Jaipur Cell received intelligence regarding two individuals transporting banned Tramadol on a motorcycle along Chhabra Road in Sodala. The team proceeded to the location and monitored the suspects. They were intercepted near the Chambal Power House on Chhabra Road in Jaipur. Upon searching the vehicle, 7920 banned Tramadol capsules and 118 bottles of Codeine Phosphate Syrup were discovered concealed within 33 boxes.

Following interrogation, the team set out to apprehend the supplier, who was detained near Balaji Petrol Pump. During the search, drugs valued at Rs 42,780 were recovered from the supplier. Upon questioning, the supplier provided information about the stockist. Consequently, the team conducted a raid on a residential complex situated on Sikar Road, where they seized 2184 Tramadol capsules, 600 Alprazolam tablets, and 97 bottles of Codeine Phosphate Syrup.

In total, the operation resulted in the recovery of 10104 smuggled Tramadol capsules, 600 Alprazolam tablets, 215 bottles of Codeine Phosphate, and cash amounting to Rs 42,780. Furthermore, three motorcycles have been confiscated, and four individuals have been arrested. The investigation is ongoing.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg